Wright Investors Service’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
EIP
Wright Investors Service's AZN Position: Q4 2017 in Review
Wright Investors Service sold out of AstraZeneca (AZN) in Q4 2017, closing a stake of 7,500 shares — an estimated $508K sold.
Wright Investors Service first reported a position in AZN in Q2 2013 and held it in 17 quarters. The position peaked at $6.08M in Q4 2013. 503 funds tracked by Wall St. Rank hold AZN as of Q4 2017.
- Wright Investors Service reported no remaining AstraZeneca position as of Q4 2017 after selling out during the quarter.
- Wright Investors Service sold 7,500 AstraZeneca shares in Q4 2017, an estimated $508K.
- Wright Investors Service first reported a position in AstraZeneca in Q2 2013 and held it in 17 quarters.
- Wright Investors Service's AstraZeneca position peaked at $6.08M in Q4 2013.
- 503 funds tracked by Wall St. Rank held AstraZeneca as of Q4 2017.
Based on Wright Investors Service's 13F filing for Q4 2017, filed 30 Jan 2018.